Literature DB >> 12716042

Coordinated expression of integrin subunits, matrix metalloproteinases (MMP), angiogenic genes and Ets transcription factors in advanced-stage ovarian carcinoma: a possible activation pathway?

Ben Davidson1, Iris Goldberg, Walter H Gotlieb, Juri Kopolovic, Bjørn Risberg, Gilad Ben-Baruch, Reuven Reich.   

Abstract

The events that mediate tumor progression in ovarian carcinoma are poorly understood to date. This review summarizes our results studying metastasis-associated molecules in advanced-stage ovarian carcinomas, details the co-expression of mRNA of these genes, and discusses their prognostic role. Fifty-five primary and metastatic FIGO stage III-IV ovarian carcinomas were analyzed for the expression of alpha v and beta1 integrin subunits, the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP, the MMP inhibitor TIMP-2, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), interleukin-8 (IL-8), PEA3 and Ets-1 using mRNA in situ hybridization. Tumor and adjacent stromal cell expression was scored. The association between integrin subunit expression and the expression of MMP, TIMP-2, angiogenic genes, PEA3 and Ets-1 was statistically analyzed. Alpha v integrin subunit mRNA expression in carcinoma cells showed significant association with that of MMP-2 and IL-8 in this cellular compartment, while the presence of beta1 integrin subunit mRNA showed similar association with that of PEA3, Ets-1, IL-8, bFGF and MMP-2. Expression of beta1 integrin subunit mRNA in stromal cells was associated with that of TIMP-2 and Ets-1 in this compartment. In addition, significant intercellular associations were found between alpha v integrin subunit mRNA expression in carcinoma cells and stromal cell expression of Ets-1, as well as between stromal cell expression of alpha v integrin subunit and labeling for IL-8 in carcinoma cells. The presence of beta1 integrin subunit mRNA in carcinoma cells showed a significant association with that of Ets-1, IL-8 and bFGF in stromal cells, while the presence of beta1 integrin subunit mRNA in stromal cells was associated with tumor PEA3 mRNA expression. To the best of our knowledge, this is the first evidence for coordinated autocrine and paracrine expression of members of these four families of metastasis-associated genes in human cancer. The results of this analysis support experimental data regarding cross-talk between carcinoma cells and peritumoral fibroblasts. They also suggest the existence of a putative activation sequence of metastatic genes, involving the beta1 (and possibly alpha v) integrin subunits, IL-8, PEA3, Ets-1 and MMP in ovarian carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716042     DOI: 10.1023/a:1022272204045

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  17 in total

1.  Migration responses of outer and inner meniscus cells to applied direct current electric fields.

Authors:  Najmuddin J Gunja; Divya Dujari; Andrew Chen; Alba Luengo; Jason V Fong; Clark T Hung
Journal:  J Orthop Res       Date:  2011-06-27       Impact factor: 3.494

2.  Ets1 transcription factor mediates gastrin-releasing peptide-induced IL-8 regulation in neuroblastoma cells.

Authors:  Jingbo Qiao; Jung-Hee Kang; Jeremy Cree; B Mark Evers; Dai H Chung
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

3.  Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways.

Authors:  Poyil Pratheeshkumar; Young-Ok Son; Sasidharan Padmaja Divya; Ram Vinod Roy; John Andrew Hitron; Lei Wang; Donghern Kim; Jin Dai; Padmaja Asha; Zhuo Zhang; Yitao Wang; Xianglin Shi
Journal:  Toxicol Appl Pharmacol       Date:  2014-10-23       Impact factor: 4.219

4.  Aberrant expression of ETS1 and ETS2 proteins in cancer.

Authors:  Elizabeth A Fry; Kazushi Inoue
Journal:  Cancer Rep Rev       Date:  2018-04-23

5.  Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.

Authors:  Kathryn M Burleson; Linda K Hansen; Amy P N Skubitz
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

6.  Poly-N-acetyl glucosamine nanofibers regulate endothelial cell movement and angiogenesis: dependency on integrin activation of Ets1.

Authors:  John N Vournakis; Juanita Eldridge; Marina Demcheva; Robin C Muise-Helmericks
Journal:  J Vasc Res       Date:  2007-12-19       Impact factor: 1.934

7.  SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathway.

Authors:  Vanessa M Freitas; Vanessa F Vilas-Boas; Daniel C Pimenta; Vania Loureiro; Maria A Juliano; Márcia R Carvalho; João J V Pinheiro; Antonio C M Camargo; Anselmo S Moriscot; Matthew P Hoffman; Ruy G Jaeger
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

8.  Ascites-induced shift along epithelial-mesenchymal spectrum in ovarian cancer cells: enhancement of their invasive behavior partly dependant on αv integrins.

Authors:  L Carduner; J Leroy-Dudal; C R Picot; O Gallet; F Carreiras; S Kellouche
Journal:  Clin Exp Metastasis       Date:  2014-06-20       Impact factor: 5.150

Review 9.  Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Authors:  Poyil Pratheeshkumar; Chakkenchath Sreekala; Zhuo Zhang; Amit Budhraja; Songze Ding; Young-Ok Son; Xin Wang; Andrew Hitron; Kim Hyun-Jung; Lei Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

10.  Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.

Authors:  Poyil Pratheeshkumar; Young-Ok Son; Amit Budhraja; Xin Wang; Songze Ding; Lei Wang; Andrew Hitron; Jeong-Chae Lee; Donghern Kim; Sasidharan Padmaja Divya; Gang Chen; Zhuo Zhang; Jia Luo; Xianglin Shi
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.